Premier Alternatives

Variantyx

Framingham, MA · Founded 2014 · Privately Held (backing)

Developer of genetic testing platform designed to improve diagnosis and personalized medicine for rare genetic disorders, reproductive genetics and precision oncology. Variantyx is based in Framingham, MA and was founded in 2014. It was valued at $98 million at its later-stage round in Apr 2024, the last priced event on record. It has raised $175 million across 1 recorded round; the latest was a $15.6 million early-stage round in Feb 2021.

PMV mark · valuation
$98.0M
Oct 2026
Priced at
its later-stage round
Apr 2024
Total raised
$175.3M
Last round
Early Stage VC
Feb 2021

Variantyx key facts

as of Oct 2026
  • Developer of genetic testing platform designed to improve diagnosis and personalized medicine for rare genetic disorders, reproductive genetics and precision oncology.
  • Variantyx is valued at approximately $98.0M as of Oct 2026, set at its later-stage round, Apr 2024; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $175.3M across 1 recorded rounds; the latest was Early Stage VC ($15.6M) in Feb 2021.
  • Notable investors include OrbiMed, Pitango Venture Capital, Bosch Ventures, Peregrine Ventures, New Era Capital Partners — 11 tracked in total.
  • Variantyx has filed 1 Form D with the SEC, most recently Mar 2021 ($15.6M sold to 8 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$98.0M

Valued at $98.0M at its later-stage round, Apr 2024. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Private Market View
More of Variantyx with a free Private Market View account
  • ·The complete investor list: 11 names
  • ·Watch Variantyx: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Variantyx funding rounds

1 rounds
Feb 2021Early Stage VC$15.6MSEC filing▮
Full funding history →

Variantyx valuation

Variantyx was valued at $98 million at its later-stage round in Apr 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Variantyx raised?

Variantyx has raised $175 million in total; 1 of its rounds is on record. The largest on record was a $15.6 million early-stage round in Feb 2021.

Variantyx has filed 1 Form D with the SEC, most recently in Mar 2021 ($15.6 million sold to 8 investors).

Variantyx investors

11 investors are on record for Variantyx, including OrbiMed, Pitango Venture Capital, Bosch Ventures and Peregrine Ventures. By type, the record holds 3 venture capital firms, 1 family office and 1 private equity firm. The early-stage round in Feb 2021 drew 8 investors.

About Variantyx

Developer of genetic testing platform designed to improve diagnosis and personalized medicine for rare genetic disorders, reproductive genetics and precision oncology. The company's platform features advanced laboratory technology, proprietary AI and machine learning analytical tools, flexible reflex testing options, and streamlined patient billing policies, enabling healthcare providers and patients to access detailed genomic analysis that supports clinical decision-making and shortens the diagnostic process.

Sector
Healthcare
HQ
Framingham, MA, United States
Founded
2014
Employees
194
Ownership
Privately Held (backing)

Is this your company? Profiles are maintained at PrivateMarketView, the data platform behind this page — sign in with your work email to keep it current, or tell us what's wrong.